Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Unproven Stem Cell Therapies for Lung Disease on the Rise

August 11, 2016 By Boston University Medical Center

Stem cell medical tourism and unproven stem cell interventions are growing and concerning issues for patients afflicted with lung disease. According to Boston University School of Medicine (BUSM) researchers, there are an increasing number of clinics worldwide offering expensive stem cell-based therapies that are ineffective or have no proven benefit.

In an editorial released online in the Annals of the American Thoracic Society, lead author Laertis Ikonomou, Ph.D., assistant professor of Molecular and Translational Medicine at BUSM and member of the Center for Regenerative Medicine explained, “Remarkably, an increasing number of these clinics now operate within the United States. It is imperative that scientific and medical societies, as well as professional respiratory disease and critical care communities speak out forcefully against stem cell tourism.”

According to Ikonomou, a lead member of the American Thoracic Society’s Stem Cell Working Group, perceptions of stem cell-based therapies can be significantly different between experts and the general public, including patients. While experts evaluate therapies based on demonstrations of safety and efficacy, many patients are motivated by hope and the desperate need for a cure.

Ikonomou and colleagues say several factors exacerbate these perceptions, including aggressive and unscrupulous advertisement of unproven stem cell therapies, uncritical and overly optimistic portrayal of stem cell clinical translation in mainstream media, use of selected and uncontrolled patient testimonials to suggest benefit and reluctance of experts to speak-out against stem cell medical tourism due to fears of litigation and political backlash.

“The problem of stem cell medical tourism of unproven, unregulated cell therapies can be best tackled through international collaboration, and engagement and education of all parties including patients, physicians and other caregivers and scientists,” Ikonomou said. “We can turn the tide on this global health problem by vigorously implementing a multi-pronged strategy that combines continuous education of the public, pressure for effective regulations and rigorous research in the field of lung regenerative medicine.”

Related Articles Read More >

What is microscale 3D printing? Lessons learned from Mayo Clinic
cleveland-clinic-disruptors-2021
The top 10 medical disruptors of 2021
6 medical device industry supplier innovations you should know
Biomedical textiles can drive innovation in orthopedics: Here’s how

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech